相关实验视频

Updated: Jul 7, 2025

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

在完整血管学再输注之前的静脉内血栓溶解:超越血管学评估以准微血管阻塞?

Benjamin Gory^1,2, Stephanos Finitsis³, Jean-Marc Olivot⁴

¹Department of Diagnostic and Therapeutic Neuroradiology, Université de Lorraine, CHRU-Nancy, Nancy, France.

Annals of neurology

|December 27, 2023

概括

在内血管治疗 (EVT) 之前先用静脉血栓溶解 (IVT) 进行预治疗,可以改善中风患者的结局,使其有完整的再输血,而不会增加出血的风险.

科学领域:

神经学神经学
干预神经病学干预神经病学
脑卒中医学脑卒中医学

背景情况:

血管内治疗 (EVT) 后的无效组织再输与糟糕的结果有关.
内静脉血栓溶解 (IVT) 可能调节再输血的有效性.
在EVT之前IVT的具体影响需要进一步澄清.

研究的目的:

为了比较患者的临床和安全结果,实现完整的EVT再注血.
评估之前使用IVT对成功EVT后的结果的影响.

主要方法:

对缺血性中风 (ETIS) 预期观察性内血管治疗注册表 (2015-2021) 的分析.
在6小时内包括前部大血管封闭和完全再输血 (TICI 3) 的患者.
倾向性得分匹配用于比较IVT+EVT和单独EVT组之间的结果.

主要成果:

在匹配的队列中 (n=825),IVT+EVT与修改的兰金尺度 (mRS) 分布的有利转变有关 (aOR=1.41,p=0.023).
在IVT+EVT组中,90天的良好结果 (mRS 0-2) 在IVT+EVT组中较高 (61.1%对48.7%,aOR=1.49,p=0.041).
症状性内出血的发病率在两组之间是相似的 (6.0%对4.3%,aOR=1.16,p=0.709).

结论:

以前使用IVT改善了中风患者的临床结果,这些患者通过EVT实现了完全的再输液.
在EVT前进行IVT并不会增加出血并发症的风险.
这一策略增强了成功的机械再注射后的功能恢复.

更多相关视频

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug

Published on: June 4, 2021

Combined Near-infrared Fluorescent Imaging and Micro-computed Tomography for Directly Visualizing Cerebral Thromboemboli

Combined Near-infrared Fluorescent Imaging and Micro-computed Tomography for Directly Visualizing Cerebral Thromboemboli

Published on: September 25, 2016

相关概念视频

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...